IDL Diagnostics AB (IDLDX)

Currency in SEK
0.57
+0.01(+2.52%)
Closed·
IDLDX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
IDLDX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.560.57
52 wk Range
0.350.66
Key Statistics
Prev. Close
0.56
Open
0.56
Day's Range
0.56-0.57
52 wk Range
0.35-0.66
Volume
117.67K
Average Volume (3m)
185.39K
1-Year Change
3.7%
Book Value / Share
0.47
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IDLDX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

IDL Diagnostics AB Company Profile

IDL Diagnostics AB (publ), a vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden. It offers UBC Rapid, a point-of-care test for diagnosis and monitoring of bladder cancer; AroCell TK 210 ELISA, a biomarker for tumor cells; and TUBEX TF, a vitro diagnostic test for detection of acute typhoid fever. The company was formerly known as AroCell AB (publ) and changed its name to IDL Diagnostics AB (publ) in May 2025. IDL Diagnostics AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.

Compare IDLDX to Peers and Sector

Metrics to compare
IDLDX
Peers
Sector
Relationship
P/E Ratio
−2.9x−3.9x−0.5x
PEG Ratio
−0.140.010.00
Price/Book
1.2x1.7x2.6x
Price / LTM Sales
2.2x2.6x3.3x
Upside (Analyst Target)
42.9%56.3%43.5%
Fair Value Upside
Unlock33.1%6.3%Unlock

Earnings

Latest Release
May 07, 2025
EPS / Forecast
-0.05 / --
Revenue / Forecast
15.30M / 17.10M
EPS Revisions
Last 90 days

IDLDX Income Statement

FAQ

What Stock Exchange Does IDL Diagnostics AB Trade On?

IDL Diagnostics AB is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for IDL Diagnostics AB?

The stock symbol for IDL Diagnostics AB is "IDLDX."

What Is the IDL Diagnostics AB Market Cap?

As of today, IDL Diagnostics AB market cap is 131.31M.

What Is IDL Diagnostics AB's Earnings Per Share (TTM)?

The IDL Diagnostics AB EPS (TTM) is -0.19.

When Is the Next IDL Diagnostics AB Earnings Date?

IDL Diagnostics AB will release its next earnings report on 22 Oct 2025.

From a Technical Analysis Perspective, Is IDLDX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has IDL Diagnostics AB Stock Split?

IDL Diagnostics AB has split 1 times.

How Many Employees Does IDL Diagnostics AB Have?

IDL Diagnostics AB has 20 employees.

What is the current trading status of IDL Diagnostics AB (IDLDX)?

As of 05 Aug 2025, IDL Diagnostics AB (IDLDX) is trading at a price of 0.57, with a previous close of 0.56. The stock has fluctuated within a day range of 0.56 to 0.57, while its 52-week range spans from 0.35 to 0.66.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.